Literature DB >> 4908935

Absorption of injected insulin. A clinical-pharmacological study.

C Binder.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4908935     DOI: 10.1111/j.1600-0773.1969.tb03069.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


× No keyword cloud information.
  49 in total

1.  Lymphatic absorption is a significant contributor to the subcutaneous bioavailability of insulin in a sheep model.

Authors:  S A Charman; D N McLennan; G A Edwards; C J Porter
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

2.  The pharmacokinetics of two different concentrations of short-acting insulin, intermediate-acting insulin, and an insulin mixture following subcutaneous injection.

Authors:  A Hübinger; W Weber; W Jung; K Wehmeyer; F A Gries
Journal:  Clin Investig       Date:  1992-07

3.  Opalescent appearance of an IgG1 antibody at high concentrations and its relationship to noncovalent association.

Authors:  Muppalla Sukumar; Brandon L Doyle; Jessica L Combs; Allen H Pekar
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

4.  A comparison of three mathematical models to describe the disappearance curves of subcutaneously injected 125I-labelled insulin.

Authors:  P H De Meijer; F G Russel; H J Van Lier; C A Van Ginneken
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

5.  Modeling absorption kinetics of subcutaneous injected soluble insulin.

Authors:  E Mosekilde; K S Jensen; C Binder; S Pramming; B Thorsteinsson
Journal:  J Pharmacokinet Biopharm       Date:  1989-02

Review 6.  Pharmacokinetic considerations of new insulin formulations and routes of administration.

Authors:  A Hoffman; E Ziv
Journal:  Clin Pharmacokinet       Date:  1997-10       Impact factor: 6.447

Review 7.  Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.

Authors:  E W Kraegen; D J Chisholm
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

8.  Low subcutaneous degradation and slow absorption of insulin in insulin-dependent diabetic patients during continuous subcutaneous insulin infusion at basal rate.

Authors:  D J Chisholm; E W Kraegen; M J Hewett; S Furler
Journal:  Diabetologia       Date:  1984-08       Impact factor: 10.122

Review 9.  Clinical pharmacokinetics and pharmacodynamics of insulin aspart.

Authors:  A Lindholm; L V Jacobsen
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

10.  Insulin responses to varying profiles of subcutaneous insulin infusion: kinetic modelling studies.

Authors:  E W Kraegen; D J Chisholm
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.